非参数模型在以等级资料为终点的非劣效性临床试验中的应用及SAS实现
被引量:1
出处
《中国卫生统计》
CSCD
北大核心
2009年第5期516-518,共3页
Chinese Journal of Health Statistics
基金
十一五"重大新药创制科技重大专项"-新药临床研究技术平台建设:数据管理和统计分析的平台建设(2008ZX09312-007和2008ZX09312-025)
参考文献10
-
1Subhabrata C,,Mark A.van de Wiel.A nonparametric control chartbased on the Mann-Whitney statistic[].Mathematical Statistics.2008
-
2Cyrus RM,,Nitin RP,Anastasios A.Tsiatis.Exact significance testing toestablish treatment equivalence with ordered categorical data[].J Interna-tional Biometric Society.1984
-
3Edgar Brunner,Ullrich Munzel.The nonparametric behrens-fisher prob-lem:asymptotic theory and a small-sample approximation[].BiometricalJournal.2000
-
4Wellek S,Hampel B.A distribution-free two-sample equivalence test al-lowing for tied observations[].Biometrical Journal.1999
-
5Neubert Karin,Brunner Edgar.A studentized permutation test for thenon-parametric Behrens-Fisher problem[].Computational Statistics.2007
-
6Wellek,S.A new approach to equivalence assessment in standard comparative bioavailability trials by means of the Mann-Whitney statistic[].Biom J.1996
-
7Z. W. Birnbaum,Orval M. Klose.Bounds for the variance of the Mann-Whitney statistic[].Annals of Mathematical Statistics.1957
-
8Munzel,U.,Hauschke,D.A nonparametric test for proving noninferiority in clinical trials with ordered categorical data[].Pharmaceutical Statistics.2003
-
9E Brunner,U Munzel.Nichtparametrische datenanalyse[]..2002
-
10Hung HMJ,Wang SJ,O’Neill RT.Aregulatory Perspective on Choice of Margin and Statistical Inference Issue in Non-inferiority Trials[].Bio-metrical J.2005
同被引文献6
-
1Berry DA. Introduction to Bayesian methods Ill: use and interpretation of Bayesian tools in design and analysis [J]. Clin Trials, 2005, 2: 295-300.
-
2Giles F. Adaptive randomized study of idarubicin and cytarabine versus troxacitabine and cytarabine versus troxacitabine and idarubicin in un- treated patients 50 years or o|der with adverse karyotype acute myeloid leukemia[J]. J Clin Oncol, 2003, 21: 1722-1727.
-
3Cyrus RM, Nitin RP, Anastasios A. Exact significance testing to es- tablish treatment equivalence with ordered categorical data[J]. Interna- tional Biometric Society, 1984, 40: 819-825.
-
4贺江南,张新佶,谢之辉,吴美京,贺佳.正态分布资料等效性评价的传统假设检验方法与贝叶斯方法比较[J].中国卫生统计,2009,26(4):422-425. 被引量:3
-
5闫宇翔,王洪源,王仁安.多临床终点的等效性检验方法探讨[J].中华流行病学杂志,2003,24(10):935-938. 被引量:3
-
6吕静静,于浩,陈峰.率的等效性检验方法的比较[J].中国临床药理学与治疗学,2004,9(3):354-357. 被引量:6
二级引证文献3
-
1张新友.证候类中药新药临床试验四诊信息采集规范探讨[J].中国继续医学教育,2015,7(27):196-197.
-
2田劭丹,董青,祁烁,贾玫,侯丽,陈信义.化疗后白细胞减少症中医药防治与评估专家共识[J].现代中医临床,2018,25(3):1-6. 被引量:48
-
3吴祥铭,刘能江.138例腹泻便病原菌患者检验结果临床研究[J].影像研究与医学应用,2017,1(8):209-211. 被引量:4
-
1吴莹,侯艳,李康.三臂非劣效临床试验的评价方法[J].中国卫生统计,2013,30(1):127-130. 被引量:1
-
2刘玉秀,姚晨,陈峰,陈启光,苏炳华,孙瑞元.临床非劣效性/等效性评价的统计学方法[J].中国临床药理学与治疗学,2000,5(4):344-349. 被引量:15
-
3侯艳,李康.非劣效性临床试验中两组率差值的协变量调整方法[J].中国卫生统计,2012,29(2):196-198. 被引量:1
-
4HOU Yan WU Xiao-yan LI Kang.Issues on the selection of non-inferiority margin in clinical trials[J].Chinese Medical Journal,2009(4):466-470. 被引量:3
-
5傅承主,陈冠民.等级资料的相关分析[J].数理医药学杂志,1992,5(1):67-69.
-
6宋剑辉,张芬芳,张源源,张凯明.美托洛尔缓释片治疗慢性心力衰竭的临床研究[J].山西医药杂志(上半月),2008,37(11):1047-1048. 被引量:2
-
7刘玉秀,姚晨,陈峰,夏结来.临床试验配对二项数据基于率比的非劣效性/等效性评价[J].中国卫生统计,2008,25(3):317-319. 被引量:7
-
8李路路,侯艳,吴莹,李康.临床试验中等级资料的记分分析方法的适用性[J].中国卫生统计,2015,32(2):350-353. 被引量:1
-
9Merle CS,Fielding K,Sow OB,康万里,唐神结.应用含加替沙星的4个月化疗方案治疗结核病[J].中华结核和呼吸杂志,2015,38(7):500-500. 被引量:1
-
10常靖,杨永利,施学忠,常亮,平智广.非劣效性/等效性检验的样本含量估计及软件实现[J].中国中医药咨讯,2011,3(17):428-428.